K Pharma: Announcements of individual stocks: Notice of online holding of IR briefing for the 2nd quarter (interim period) financial results for the fiscal year ending December 2024, for individual investors.
K Pharma: Announcements of individual stocks: Notice of participation in the 3rd Asset Management Expo [Summer] IR and stock investment fair.
K PHARMA: Announcement of release of analyst reports by WelsAdvisor Co., Ltd.
K PHARMA: Notice of update of financial results report for the 1st quarter of the fiscal year ending 2024/12
K PHARMA: Announcement of publication of the analyst report (English version) by Shared Research Co., Ltd.
K Pharma: Matters relating to business plans and growth potential
K-Pharma: Announcement of release of analyst reports by Shared Research Co., Ltd.
K Pharma: Notice Concerning Decrease in the Amount of Capital (Capital Reduction) and Disposal of Surplus Funds
K Pharma: Notice of patent assessment for manufacturing Tau-related disease models in Japan
K Pharma: Notice Concerning the Recording of Non-Operating Expenses (IPO Costs and Stock Grant Expenses)
K Pharma: Independent Officer Notification Form
K Pharma: Articles of Incorporation 2023/08/06
K Pharma: Matters relating to business plans and growth potential
K Pharma: Notice Concerning Changes in Major Shareholders
K Pharma: Notice of our financial results information etc. associated with listing on the Tokyo Stock Exchange Growth Market
K Pharma: (Additional) Revised securities report for listing application
K Pharma: Confirmation of the appropriateness of securities reports, etc. for listing applications
K Pharma: Quarterly Report for Listing Applications (2nd quarter)
K Pharma: Quarterly Report for Listing Applications (First quarter)
K Pharma: Securities reports for listing applications
No Data